NYSE: SLQTSelectquote Inc Stock
$3.24+0.05 (+1.57%)
Updated Apr 17, 2025
SLQT Price
$3.24
Fair Value Price
N/A
Market Cap
$557.75M
52 Week Low
$1.48
52 Week High
$6.86
P/E
-40.5x
P/B
1.71x
P/S
0.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.46B
Earnings
-$13.78M
Gross Margin
43.1%
Operating Margin
5.69%
Profit Margin
-0.9%
Debt to Equity
2.92
Operating Cash Flow
$19M
Beta
2.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SLQT Overview
Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health and property. The company pioneered the direct-to-consumer model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a force of more than 1,000 highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources, scores, and routes high-quality sales leads. The company has three core business lines: SelectQuote Senior, SelectQuote Life and SelectQuote Auto and Home. SelectQuote Senior, the largest and fastest-growing business, serves the needs of a demographic that sees 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans from 15 leading, nationally-recognized carriers, as well as prescription drug plan, dental, vision and hearing plans.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SLQT's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important SLQT news, forecast changes, insider trades & much more!
SLQT News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SLQT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SLQT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SLQT is good value based on its book value relative to its share price (1.71x), compared to the US Insurance Brokers industry average (6.2x)
P/B vs Industry Valuation
SLQT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SLQT due diligence checks available for Premium users.
Valuation
SLQT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-40.5x
Industry
1.62x
Market
27.98x
SLQT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.71x
Industry
6.2x
SLQT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SLQT's financial health
Profit margin
Revenue
$481.1M
Net Income
$53.2M
Profit Margin
11.1%
SLQT's Earnings (EBIT) of $82.93M... subscribe to Premium to read more.
Interest Coverage Financials
SLQT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3B
Liabilities
$953.2M
Debt to equity
2.92
SLQT's short-term assets ($372.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SLQT's long-term liabilities ($758.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SLQT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$28.7M
Investing
-$2.3M
Financing
$34.2M
SLQT's operating cash flow ($19.17M)... subscribe to Premium to read more.
Debt Coverage Financials
SLQT vs Insurance Stocks
Selectquote Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.